Alves et al. (2016) [51] mention that leptin, ghrelin, and glucagon-like peptide-1 are pharmacologically relevant, since these hormones regulate glucose homeostasis in the body and may be ideal targets for anti-obesity therapy. This evidence concerns the gene GHRL and obesity disorder.